Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:48 AM
Ignite Modification Date:
2025-12-25 @ 4:48 AM
NCT ID:
NCT00388518
Eligibility Criteria:
Inclusion Criteria:
* adult patients, 18-75 years of age;
* type 2 diabetes, diagnosed \>=1 month of screening;
* either drug-naive, or pretreated with a maximum of 2 oral antihyperglycemic agents at submaximal doses;
* HbA1c \<=10.0% at screening, and 7.0-10.0% at pre-randomisation visit.
Exclusion Criteria:
* type 1 diabetes;
* currently or previously treated with insulin, a thiazolidinedione, or a dual Peroxisome Proliferator Activated Receptor (PPAR) agonist;
* clinically significant cardiovascular disease;
* Congestive Heart Failure (CHF) New York Heart Association (NYHA) 3-4.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00388518
Study Brief:
Protocol Section:
NCT00388518